Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Synbiotic (Pre + Probiotic)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Antibiotic-associated diarrhoea (prevention)
- Acute infective diarrhoea (adjunct)
- Irritable bowel syndrome (IBS)
- Traveller's diarrhoea prevention
- Post-antibiotic gut restoration
Mechanism of Action
Probiotics are live beneficial microorganisms (Lactobacillus, Bifidobacterium spp.) that colonise gut, compete with pathogens, produce antimicrobial substances, strengthen gut barrier function, and modulate immune responses. Reduce antibiotic-associated diarrhoea by 50% per Cochrane meta-analyses.
Dosage & Administration
- Adults: 1 capsule twice daily.
Side Effects
- Mild bloating, flatulence (initial).
- Rare bacteraemia in immunocompromised.
Contraindications
- Severe immunocompromise (relative), central venous catheter in situ, severe pancreatitis (relative).
Storage
Store between 2–25 °C in dry place.
PCD Pharma Franchise for Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet?
Available pack sizes include: 10 x 10.
What is the MRP / trade price for Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet?
MRPs range from ₹1045 to ₹1045 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Pre-Probiotic (blend of Lactobacillus Acidophillus, Lactobacillus Rhamonsus, Bifidobacterium Longum, Sacchromyces Boulardii) 2.75 billion cfu Tablet?